Erba Transasia Group, India’s leading InVitro Diagnostic company, is proud to announce a groundbreaking achievement: it has become the first company in India to receive the Bureau of Indian Standards (BIS) certificate for its fully automated range of clinical chemistry analyzers, including the XL 200/EM
Beta-thalassemia is a hereditary blood disorder characterized by reduced or absent synthesis of the beta chains of hemoglobin, leading to decreased production of functional hemoglobin. This condition affects millions of people worldwide, particularly those of Mediterranean, Middle Eastern, and Southeast Asian descent. While beta-thalassemia manifests
Unfortunate to see PM’s ‘Make in India’ dream being bulldozed: AiMeD In an unprecedented move, India’s leading industry body – FICCI’s Medical Devices Division – joins hands with forces inimical to the Make in India drive of Prime Minister Narendra Modi, giving a body blow
Medical Services and Infrastructure Development Corporation (APMSIDC) to facilitate the supply of Erba range of fully/semi-automated biochemistry analyzers, coagulation analyzers and urine chemistry analyzers. These are being installed in several Primary Health Centres, Urban Primary Health Centres, Community Health and Wellness Centres, Sub-District Hospitals and District
Transasia Bio-Medicals Ltd., India’s Leading In-vitro Diagnostic Company, has donated over 5 lakh tablets worth more than Rs. 50 lakhs for recovery of COVID-19 patients. These medicines have been identified as a part of India’s COVID-19 treatment protocol and are enabling in mitigating the widespread
Transasia Bio-Medicals, a leading global company focusing on delivering innovative, affordable, and sustainable healthcare solutions, has donated 200 ventilators to various government hospitals to fight against the deadly pandemic. As the situation escalates in the country there has been a wide shortage of ventilators across various
